HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Methacrylate Ingredients Designated Safe For Professional Use By CIR

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel concluded its tentative final review of the methacrylate ingredient class with a "safe as used" by professionals designation at a meeting in Washington, D.C. Sept. 10-11. At the session, 19 methacrylate monomers were determined to be safe under current use conditions based on data recently supplied to the panel.

You may also be interested in...



CIR "Proactive" Approach To Seeking Controversial Ingredients Data Urged

The Cosmetic Ingredient Review Expert Panel should be "proactive" in conducting literature searches on controversial cosmetic ingredients up for re-review, CIR Director and Scientific Coordinator Alan Anderson urged during the panel's Sept. 10-11 meeting in Washington, D.C.

CIR "Proactive" Approach To Seeking Controversial Ingredients Data Urged

The Cosmetic Ingredient Review Expert Panel should be "proactive" in conducting literature searches on controversial cosmetic ingredients up for re-review, CIR Director and Scientific Coordinator Alan Anderson urged during the panel's Sept. 10-11 meeting in Washington, D.C.

Phthalates "Safe As Used" Recommendation To Be Reevaluated By CIR

The Cosmetic Ingredient Review Expert Panel will reevaluate its 1984 "safe as used" conclusion on dibutyl, dimethyl and diethyl phthalates beginning at its Nov. 29-30 meeting. The board voted unanimously to re-review phthalates during a June 4-5 meeting in Washington, D.C.

Related Content

UsernamePublicRestriction

Register

RS009627

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel